What Happened
A nurse at St. Vincent Healthcare in Billings, Montana, swapped a patient's prescribed opioid pain medication for an over-the-counter substitute to feed her own drug use.
On December 6, 2018, she replaced a patient's packaged hydrocodone with generic over-the-counter acetaminophen, then kept the hydrocodone for herself. The switch was discovered because the patient noticed she was being given different-looking pills by this nurse than by other nurses, and reported experiencing considerably more pain during her shifts than during other nurses' shifts.
When confronted by a manager and the human resources director, she first denied wrongdoing but then admitted she had taken the patient's pain pills, used them, and replaced them with an over-the-counter medication. She admitted to law enforcement that she had become addicted to the pills. She pleaded guilty to tampering with a consumer product and was sentenced on October 29, 2019, to four years of probation.
What Went Wrong
Detection depended entirely on an alert patient noticing a difference in pill appearance and pain control, not on any system control. Key failures included:
- No independent verification confirmed that pills administered to a patient matched what was actually dispensed from the pharmacy for that patient.
- Patient-reported pain-control complaints tied to a specific nurse's shifts were not systematically tracked as a possible diversion indicator.
- No physical check of "administered" medication packaging occurred at the bedside to confirm it matched the prescribed drug.
How It Could Have Been Prevented
- Implement bedside barcode scanning that verifies the physical medication matches the pharmacy-dispensed product before administration.
- Track patient complaints of inadequate pain control by nurse and shift, escalating clusters tied to one caregiver for review.
- Require a second clinician to co-sign or witness administration of high-risk oral opioids in acute care settings.
- Train frontline staff and patients to report visibly different pills or packaging as a potential safety and diversion concern.
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators including patient complaints of poor pain control.
- Hospital Diversion Prevention Checklist — Hospital self-assessment covering bedside administration controls.
- Employee Screening & Fitness for Duty — DEA screening requirements (21 C.F.R. §1301.90) for staff with controlled substance access.
- Patient Notification After Drug Diversion — When and how to notify potentially exposed patients.